Authors

  • Arifov S.S., Nosirjonov M.A.

Keywords:

vasomotor rhinitis; topical decongestants; rhinitis medicamentosa; pharmacological tolerance; rebound nasal obstruction.

References

1. Birinci M, Ozdemir D, Pusuroglu M, Sevim Ö, Yemiş T, Cihan SN, et al. Rhinitis medicomentosa and substance addiction. European Archives of Oto-Rhino-Laryngology. 2024;281(10):5255-9.

2. Fowler J, Chin CJ, Massoud E. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists. J Otolaryngol Head Neck Surg. 2019;48(1):70.

3. Graf P, HallÉN H, Juto JE. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. Clinical & Experimental Allergy. 1995;25(5):395-400.

4. Graf P. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Rhinology. 1996;34(1):9-13.

5. Knipping S, Holzhausen HJ, Riederer A, Bloching M. Ultrastrukturelle Veränderungen der Nasenschleimhaut des Menschen nach Abusus von topischen α-Sympathomimetika. HNO. 2006;54(10):742-8.

6. Lakatos L, Koltai BG, Ferencz V, Demetrovics Z, Rácz J. Does nose spray addiction exist? A qualitative analysis of addiction components in rhinitis medicamentosa. J Behav Addict. 2025;14(1):548-60.

7. Lin C-Y, Cheng P-H, Fang S-Y. Mucosal Changes in Rhinitis Medicamentosa. Annals of Otology, Rhinology & Laryngology. 2004;113(2):147-51.

8. Mortuaire G, de Gabory L, François M, Massé G, Bloch F, Brion N, et al. Rebound congestion and rhinitis medicamentosa: Nasal decongestants in clinical practice. Critical review of the literature by a medical panel. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2013;130(3):137-44.

9. Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol. 2006;16(3):148-55.

10. Zucker SM, Barton BM, McCoul ED. Management of Rhinitis Medicamentosa: A Systematic Review. Otolaryngology–Head and Neck Surgery. 2019;160(3):429-38.